Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first moderate or severe COPD exacerbation (HR 1.09, 95% CI 1.04-1.14 ...

DOI: 10.1136/bmj-2024-080409 Meng-Ting Wang et al, Environmentally friendly inhaler regimens for COPD, BMJ (2024). DOI: 10.1136/bmj.q2825 ...

Medically reviewed by Brian Bezack, DO Inhalers are medical devices used to deliver a dose of medication into your lungs to ...

AstraZeneca may mount a challenge to GlaxoSmithKline’s three-in-one inhaler for chronic obstructive pulmonary disease (COPD) after a late-stage trial success. AZ’s single inhaler, PT010 ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

Biologics are injected medications derived from living cells ... that should lead to better symptom management. “With COPD, a ...

while another thousand were given the most common globally used inhaler. A further 500 were given the triple combination but in two inhalers. COPD is term used to describe a number of progressive lung ...

Poor adherence to treatment is a common issue in COPD patients and frequently results ... to partner with in the development of smart inhalers. Virtually all the companies active in the ...

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...